Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data
Go back to Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data| (NASDAQ: PALI) | Delayed: 1.95 -0.05 (2.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $ | |||
| Open | $2.02 | 52 Week Low | $ | |||
| Day High | $2.02 | P/E | N/A | |||
| Day Low | $1.93 | EPS | $ | |||
| Volume | 1,645,687 | |||||
